[TVTX] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
27-Oct-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -3.91%
YoY- -95.45%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 59,697 56,993 55,868 53,496 54,167 48,487 57,249 2.83%
PBT -85,565 -86,253 -65,760 -69,511 -66,979 -75,919 -51,569 40.28%
Tax 65 78 63 145 53 52 4 544.84%
NP -85,630 -86,331 -65,823 -69,656 -67,032 -75,971 -51,573 40.34%
Tax Rate - - - - - - - -
Total Cost 145,327 143,324 121,691 123,152 121,199 124,458 108,822 21.33%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -143.44 -151.48 -117.82 -130.21 -123.75 -156.68 -90.09 36.46%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -1.13 -1.27 -1.03 -1.09 -1.05 -1.20 -0.84 21.92%
EPS Diluted -1.13 -1.27 -1.03 -1.09 -1.05 -1.20 -0.84 21.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.